FDA Inspection 866095 — Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)
The FDA completed an inspection of Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) on December 20, 2013 in Wenzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 20, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wenzhou (China)